Association between Cardiovascular Health Score and Carotid Intima-Media Thickness: Cross-Sectional Analysis of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Baseline Assessment




Background


The American Heart Association aims to reduce the burden of cardiovascular disease in this decade by improving seven ideal cardiovascular health (CVH) characteristics in the population. The aim of this study was to quantify the association between the American Heart Association’s CVH score and values for carotid intima-media thickness (CIMT) in the Brazilian Longitudinal Study of Adult Health baseline assessment.


Methods


The Brazilian Longitudinal Study of Adult Health is a multicenter cohort study of civil servants aged 35 to 74 years in Brazil. In this study, the investigators analyzed 9,662 individuals with no previous cardiovascular disease. The distribution of CIMT values (categorized into age-, sex-, and race-specific quartiles) was analyzed according to CVH scores using χ 2 trend tests. Linear and multinomial regression models were built to evaluate the association between CIMT and CVH score.


Results


A significant increase was observed in the proportion of individuals within the first and second CIMT quartiles, as well as a decrease within the fourth quartile with higher CVH score strata ( P for trend < .001). A 1-point increase in CVH score was associated in adjusted models with a decrease of 0.011 mm in CIMT and an odds ratio of 0.79 (95% CI, 0.77–0.81) of having CIMT in the fourth quartile. However, nearly 16% of individuals with optimal CVH scores had CIMT values in the highest quartile.


Conclusions


In this study, significant associations were found between CIMT and CVH score in a large sample of middle-aged adults. However, a high CVH score did not warrant the absence of a significant subclinical atherosclerotic burden.


Highlights





  • Life’s Simple 7 is an AHA strategy to improve CVH in populations.



  • The CVH score measures Life’s Simple 7 metrics.



  • A direct association was found between CIMT and CVH score.



  • A 1-point increase in CVH score is associated with a mean 0.011-mm decrease in CIMT.



  • However, 16% of individuals with optimal CVH scores had high CIMT values.



In 2010, the American Heart Association (AHA) set a goal for the present decade to reduce the burden of cardiovascular disease in the American population by 20%. To reach this goal, the AHA stimulates population-based strategies to increase the proportion of individuals with ideal cardiovascular health (CVH) characteristics (Life’s Simple 7). As part of these strategies, the AHA proposes a score, composed of seven metrics, to evaluate CVH behaviors (diet, physical activity, smoking habit, and body mass index) and CVH clinical factors (blood pressure, fasting glucose, and total cholesterol).


The burden of cardiovascular disease is high worldwide, and the AHA proposal is suitable for many other countries as well. Therefore, epidemiologic studies that evaluate the frequency of ideal CVH components, assessing the associations between these CVH metrics and their putative determinants, the markers of subclinical and clinical cardiovascular disease, are important to estimate the impact on the health of populations.


Carotid intima-media thickness (CIMT) measurement via ultrasound is associated with traditional cardiovascular risk factors and is used as a noninvasive marker of early atherosclerotic disease. It has been used as a surrogate measurement in epidemiologic studies and is a predictor of cardiovascular events. Some investigators have studied the association between CIMT and the CVH score proposed by AHA. Most studies show an association between higher CVH score and lower CIMT alone or in combination with other markers of subclinical cardiovascular disease. On the other hand, Alman et al. , in an analysis of 190 individuals with type 1 diabetes from the SEARCH for Diabetes in Youth study, found an association between CVH score and pulse-wave velocity as well as brachial distensibility, but not with CIMT. Recently, Sturlaugsdottir et al. evaluated 219 older participants of the Age, Gene/Environment Susceptibility Reykjavik study (mean age, 75.6 years) and found no association between CVH score and CIMT progression after 5 years, for both sexes.


The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) is a large multicenter cohort study in six Brazilian cities. Baseline assessment included collecting data about CVH behaviors and factors, as well as measuring CIMT as part of the evaluation of subclinical atherosclerosis. This makes ELSA-Brasil a very good context for studying the association between CVH score and CIMT in a large sample outside the United States and Europe. The aim of the present study was to evaluate the association between CVH score and CIMT in the ELSA-Brasil baseline assessment.


Methods


Study Setting


The ELSA-Brasil study design and cohort profile have been published elsewhere. Briefly, it is a multicenter cohort study of 15,105 civil servants from six cities in Brazil (São Paulo, Belo Horizonte, Porto Alegre, Salvador, Rio de Janeiro, and Vitória). All active or retired employees of the six institutions aged 35 to 74 years were eligible for the study. Exclusion criteria were current or recent (<4 months before the first interview) pregnancy, intention to quit working at the institution in the near future, severe cognitive or communicative impairment, and, if retired, residence outside of a study center’s corresponding metropolitan area. The baseline assessment was a 7-hour onsite examination that included validated questionnaires and clinical and laboratory examinations. This assessment took place from August 2008 to December 2010. Approvals were granted from institutional review boards at all centers, and all individuals signed informed consent agreements.


Study Sample


In the ELSA-Brasil baseline, 13,205 of the study participants (87.4%) underwent CIMT evaluation for both common carotid arteries. After image quality control, we had valid CIMT measurements in both sides for 10,943 of 15,105 participants (72.4%). The study sample definition is displayed in Figure 1 , and a comparison between included and excluded participants is shown in Supplemental Table 1 .




Figure 1


Study sample definition.


Study Variables


In the ELSA-Brasil baseline assessment, race was self-defined according to the classification of the Brazilian national census. The protocol for CIMT measurement has been detailed in previous publications. In brief, a standardized protocol was applied at all centers using a clinical ultrasound scanner (Aplio XG; Toshiba, Tokyo, Japan) with a 7.5-MHz linear transducer. Common carotid artery intima-media thickness measurements were electrocardiographically gated (during three cardiac cycles) and performed in the far wall of a predefined carotid segment 1 cm in length measured from 1 cm below the carotid bifurcation. All participating centers obtained the carotid images and sent these acquisitions to the centralized core reading center in São Paulo. After image quality control, readings were electrocardiographically gated, and the measurements were automated using MIA software, standardizing the interpretation of the carotid scans.


For the main analyses in this report, we defined CIMT as the average of the mean left CIMT and the mean right CIMT values within an individual. Sensitivity analyses were also performed using maximal CIMT (from both common carotid arteries). We analyzed CIMT as a continuous variable and according to the distribution of values within the sample. In a previous study, we used quantile regression model techniques to describe age-, sex-, and race-specific CIMT quartiles for the sample. In this analysis, we also categorized participants according to these modeled quartiles. This procedure was also used in another publication and established the current standard for the Brazilian population. Of particular interest, the cutoff at the 75th percentile of CIMT for a given age, sex, and race (i.e., the fourth quartile in quantile regression models) is considered to be a marker for increased cardiovascular risk. To better contextualize the results of our analysis, we describe in Supplemental Table 2 the 25th, 50th, and 75th percentiles for CIMT values in ELSA-Brasil participants at ages 40, 50, and 60 years.


The definition and scoring for CVH in this analysis was based on the definitions used by the AHA. We evaluated the seven components of the CVH score (diet, physical activity, smoking, body mass index, blood pressure, fasting plasma glucose, and total cholesterol) for each participant and attributed scores of 0, 1, and 2 points, corresponding to poor, intermediate, and ideal profiles ( Table 1 ). The CVH score was calculated as the sum of the individual components (range, 0–14 points). For some analyses, the CVH score was classified as “inadequate” (0–4 points), “average” (5–9 points), or “optimal” (10–14 points). This classification has been used by others.



Table 1

Cardiovascular health score criteria




























































































CVH metric Score (points) Definition
Diet Ideal (2) Four or five adequate components
Intermediate (1) Two or three adequate components
Poor (0) Zero or one adequate component
Physical activity Ideal (2) ≥75 min/wk of vigorous physical activity, or ≥150 min/wk of moderate physical activity, or ≥150 min/wk of moderate plus vigorous physical activity
Intermediate (1) 1–149 min/wk of moderate plus vigorous activity
Poor (0) No moderate and/or vigorous physical activity
Smoking Ideal (2) Never smoked or
Former smoker; age at quitting ≥2 y less than age at baseline
Intermediate (1) Former smoker; age at quitting <2 y less than age at baseline
Poor (0) Current smoker
BMI Ideal (2) BMI < 25 kg/m 2
Intermediate (1) BMI ≥ 25 kg/m 2 and BMI < 30 kg/m 2
Poor (0) BMI ≥ 30 kg/m 2
Blood pressure Ideal (2) SBP < 120 mm Hg and DBP < 80 mm Hg, without antihypertensive medication
Intermediate (1) No ideal criteria plus:

  • (1)

    Without antihypertensive medication: SBP < 140 mm Hg and DBP < 90 mm Hg or


  • (2)

    With antihypertensive medication: SBP < 120 mm Hg and DBP < 80 mm Hg

Poor (0) No ideal or intermediate criteria
FPG Ideal (2) FPG < 100 mg/dl without hypoglycemic medication
Intermediate (1) No ideal criteria plus:

  • (1)

    Without hypoglycemic medication: FPG < 126 mg/dL or


  • (2)

    With hypoglycemic medication use: FPG < 100 mg/dL

Poor (0) No ideal or intermediate criteria
TC Ideal (2) TC < 200 mg/dL without lipid-lowering medication
Intermediate (1) No ideal criteria plus:

  • (1)

    Without lipid-lowering medication: TC < 240 mg/dL or


  • (2)

    With lipid-lowering medication: TC < 200 mg/dL

Poor (0) No ideal or intermediate criteria

BMI , Body mass index; DBP , diastolic blood pressure; FPG , fasting plasma glucose; SBP , systolic blood pressure; TC , total cholesterol.

Diet components: (1) fruits and vegetables, (2) fish, (3) fiber-rich whole grains, (4) sodium, (5) sugar-sweetened beverages.



Information from a food frequency questionnaire was used to calculate all five CVH score components related to diet. We considered the following intake of food components to be adequate: four or more servings of fruit and vegetables per day, ≥7 oz of fish per week, two or more servings of fiber-rich whole grains per day, and ≤450 kcal of sugar-sweetened beverages per week. Sodium consumption was corrected for total energy intake, and sodium consumption of <1,500 mg/d was considered adequate. We evaluated physical activity using the leisure and transportation domains of the International Physical Activity Questionnaire. We considered the AHA standard for physical activity as ideal, consisting of a minimum of 75 min/wk of vigorous activity, 150 min/wk of moderate activity, or 150 min/wk of moderate plus vigorous activity. Time of moderate plus vigorous physical activity between 1 and 149 min/week was considered intermediate, and absence of moderate and/or vigorous physical activity was considered poor. Smoking was assessed by self-report. Past smokers also stated the age at which they stopped smoking. Individuals with ideal smoking profiles were those who had never smoked or whose age at quitting smoking was ≥2 years less than their current age. Individuals with intermediate smoking profiles were past smokers whose age at quitting smoking was <2 years less than their current age.


Criteria for body mass index, blood pressure, fasting plasma glucose, and total cholesterol were the same as those proposed by AHA ( Table 1 ). The anthropometric measurements in ELSA-Brasil were assessed using standard techniques, and body mass index was calculated by dividing weight by the square of height. As in previous publications, the use of medications was classified according to the Anatomical Therapeutic Chemical Classification System codes. Use of antihypertensive medications was defined as the use of medications under codes C02, C03, C07, C08, and C09. Use of hypoglycemic medications was defined as the use of medications under code A10. Use of lipid-lowering medications was defined as the use of medications under code C10.


Statistical Analysis


Categorical variables are presented as proportions and compared using χ 2 or Fisher exact tests. Continuous variables are presented as mean ± SD or as median (interquartile range) and were compared using one-way analysis of variance or Kruskal-Wallis tests, as applicable. We analyzed the distribution of CIMT values (categorized in age-, sex-, and race-specific quartiles) according to CVH score as a discrete variable or categorized into strata (inadequate, average, or optimal), using χ 2 trend tests for proportions. In addition, we describe the Pearson correlation for the association between CIMT value and CVH score.


We built linear regression models to evaluate the association between CIMT (in millimeters) and CVH score. We present the crude models as well as models adjusted for age, sex, and race. We tested the main models (using both mean and maximal CIMT) for heteroscedasticity of the residuals using the Breusch-Pagan test. Because the tests rejected the null hypothesis, we calculated standard errors and P values using White-corrected covariance matrices. In addition, we performed a systematic search for potential influential points in the main models using the following four measurements: DFFITS, Cook’s distance, leverage values, and covariance ratio. Excluding the observations identified as potential influential points in any of these procedures did not alter significantly the results. Finally, we calculated the variance inflation factors for the independent variables in the main models (age, sex, race, and CVH score). Variance inflation factors were all <1.1, showing the absence of significant multicollinearity. Because CIMT values differ according to sex and race, and β coefficients in linear models may be sensitive to this distribution, we also present models stratified by sex and stratified by race. In addition, we describe the odds ratios from multinomial regression models for the association of CIMT age-, sex-, and race-specific modeled quartiles with CVH score.


As a sensitivity analysis, to reduce the possibility of reverse causation mediated by the adoption of positive lifestyle habits due to nonpharmacologic treatment of hypertension, diabetes or dyslipidemia, we also repeated the analyses while restricting the sample to the 4,505 individuals without self-reported diagnoses of hypertension, diabetes, and/or dyslipidemia in the ELSA-Brasil baseline assessment. The significance level was set at .05. We used R software version 3.2.0 to conduct the analyses.




Results


Tables 2 and 3 shows the characteristics of the study sample, according to CIMT classification in age-, sex-, and race-specific quartiles. Individuals in the fourth age-, sex-, and race-specific CIMT quartiles were more frequently current smokers and had higher mean body mass index, systolic and diastolic blood pressures, fasting plasma glucose, total and low-density lipoprotein cholesterol, and triglycerides and lower mean high-density lipoprotein cholesterol ( P < .001 for all comparisons). They also used antihypertensive ( P < .001), hypoglycemic ( P < .001), and lipid-lowering ( P = .001) medications more frequently. Regarding the CVH metrics, with the exception of the diet component ( P = .78), all other metrics had worse distributions in the fourth age-, sex-, and race-specific CIMT quartile group ( P = .011 for physical activity, P = .001 for smoking, P < .001 for all other comparisons). This resulted in lower global, lifestyle, and clinical CVH scores for that group ( P < .001 for all comparisons).



Table 2

Study sample characteristics according to the CIMT classification in age-, sex-, and race-specific quartiles


















































































































Variable CIMT in the first to third quartiles ( n = 7,263) CIMT in the fourth quartile ( n = 2,399) Total ( n = 9,662)
Age (y) 51.5 ± 8.9 51.4 ± 9.0 51.5 ± 8.9
Male sex 3,225 (44.4%) 1,044 (43.5%) 4,269 (44.2%)
Race
White 4,219 (58.1%) 1,388 (57.9%) 5,607 (58.0%)
Brown 1,911 (26.3%) 634 (26.4%) 2,545 (26.3%)
Black 1,133 (15.6%) 377 (15.7%) 1,510 (15.6%)
Smoking status
Never 4,279 (58.9%) 1,299 (54.1%) 5,578 (57.7%)
Past 2,070 (28.5%) 728 (30.3%) 2,798 (29.0%)
Current 914 (12.6%) 372 (15.5%) 1,286 (13.3%)
Body mass index (kg/m 2 ) 26.4 ± 4.4 28.1 ± 4.9 26.9 ± 4.6
Systolic blood pressure (mm Hg) 118.8 ± 15.9 124.9 ± 18.1 120.3 ± 16.7
Diastolic blood pressure (mm Hg) 75.0 ± 10.3 78.2 ± 11.4 75.8 ± 10.7
Fasting plasma glucose (mg/dL) 108.6 ± 24.4 114.6 ± 35.1 110.1 ± 27.6
Total cholesterol (mg/dL) 212.8 ± 41.2 220.9 ± 42.3 214.8 ± 41.7
LDL cholesterol (mg/dL) 129.6 ± 33.8 136.3 ± 34.6 131.3 ± 34.1
HDL cholesterol (mg/dL) 57.5 ± 14.7 55.5 ± 14.1 57.0 ± 14.6
Triglycerides (mg/dL) 108.5 (77.0–156.0) 125.0 (91.0–180.0) 112.0 (80.0–162.0)
Use of antihypertensive medication 1,702 (23.4%) 805 (33.5%) 2,507 (25.9%)
Use of hypoglycemic medication 448 (6.2%) 250 (10.4%) 698 (7.2%)
Use of lipid-lowering medication 772 (10.6%) 317 (13.2%) 1,089 (11.3%)

HDL , High-density lipoprotein; LDL , low-density lipoprotein.

Data are expressed as mean ± SD, as number (percentage), or as median (interquartile range).


Table 3

Distribution of CVH metrics and scores according to the CIMT classification in age-, sex-, and race-specific quartiles





























































































































































































Classification/score CIMT in the first to third quartiles ( n = 7,263) CIMT in the fourth quartile ( n = 2,399) Total ( n = 9,662)
Diet
Ideal 108 (1.5%) 31 (1.3%) 139 (1.4%)
Intermediate 2,756 (37.9%) 910 (37.9%) 3,666 (37.9%)
Poor 4,399 (60.6%) 1,458 (60.8%) 5,857 (60.6%)
Physical activity
Ideal 1,892 (26.0%) 579 (24.1%) 2,471 (25.6%)
Intermediate 967 (13.3%) 284 (11.8%) 1,251 (12.9%)
Poor 4,404 (60.6%) 1,536 (64.0%) 5,940 (61.5%)
Smoking
Ideal 6,211 (85.5%) 1,979 (82.5%) 8,190 (84.8%)
Intermediate 138 (1.9%) 48 (2.0%) 186 (1.9%)
Poor 914 (12.6%) 372 (15.5%) 1,286 (13.3%)
Body-mass index
Ideal 2,918 (40.2%) 639 (26.6%) 3,557 (36.8%)
Intermediate 2,908 (40.0%) 1,010 (42.1%) 3,918 (40.6%)
Poor 1,437 (19.8%) 750 (31.3%) 2,187 (22.6%)
Blood pressure
Ideal 3,356 (46.2%) 743 (31.0%) 4,099 (42.4%)
Intermediate 2,245 (30.9%) 765 (31.9%) 3,010 (31.2%)
Poor 1,662 (22.9%) 891 (37.1%) 2,553 (26.4%)
Fasting glucose
Ideal 2,316 (31.9%) 589 (24.6%) 2,905 (30.1%)
Intermediate 4,122 (56.8%) 1,389 (57.9%) 5,511 (57.0%)
Poor 825 (11.4%) 421 (17.5%) 1,246 (12.9%)
Total cholesterol
Ideal 2,475 (34.1%) 612 (25.5%) 3,087 (31.9%)
Intermediate 4,199 (57.8%) 1,442 (60.1%) 5,641 (58.4%)
Poor 589 (8.1%) 345 (14.4%) 934 (9.7%)
CVH scores
Global 7.7 ± 2.2 6.7 ± 2.3 7.5 ± 2.3
Lifestyle 4.0 ± 1.6 3.6 ± 1.6 3.9 ± 1.6
Clinical 3.7 ± 1.4 3.1 ± 1.5 3.6 ± 1.5
CVH score classification
Inadequate 583 (8.0%) 399 (16.6%) 982 (10.2%)
Average 5,100 (70.2%) 1,691 (70.5%) 6,791 (70.3%)
Optimum 1,580 (21.8%) 309 (12.9%) 1,889 (19.6%)

Data are expressed as number (percentage) or as mean ± SD.


The Pearson correlation coefficient between CVH scores and CIMT values was −0.32 ( P < .001). We observed a significant rise in the proportion of individuals within the first and second age-, sex-, and race-specific CIMT quartiles with higher CVH score strata ( Figure 2 ). In addition, we observed a decrease in the proportion of individuals within the fourth CIMT quartile with higher CVH score strata ( P for trend < .001 for all comparisons). Similar results were observed when analyzing CVH scores as a discrete measurement (range, 0–14; P for trend < .001 for all comparisons). A nonsignificant trend toward a decrease in the proportion of individuals in the third CIMT quartile with higher CVH scores, as both a stratified ( P for trend = .059) and a discrete ( P for trend = .098) variable, was also seen. As a sensitivity analysis, we present the distribution of age-, sex-, and race-specific CIMT quartiles according to CVH score strata when restricting the sample to 4,505 individuals without self-reported diagnoses of hypertension, diabetes, and/or dyslipidemia in the ELSA-Brasil baseline assessment. We obtained similar results for the trend tests for proportions in this subsample. We found increasing proportions of individuals in the first and second CIMT quartiles ( P for trend < .001 for both) and decreasing proportions of individuals in the third ( P for trend = .017) and fourth ( P for trend < .001) CIMT quartiles with higher CVH score strata. P values for trends using CVH scores as a discrete variable were <.001, <.001, .051, and <.001 for the first to fourth CIMT quartiles, respectively. However, as can be seen in Figure 2 , nearly 16% of individuals with optimal CVH scores had CIMT values in the highest age-, sex-, and race-specific quartile. We describe in Table 4 the characteristics of individuals with optimal CVH scores, according to CIMT classification in age-, sex-, and race-specific quartiles. We did not find differences according to smoking status in both groups ( P = .28), but those in the highest quartile had higher body mass index ( P = .001), higher low-density lipoprotein cholesterol ( P = .001), higher triglycerides ( P = .047), and a higher frequency of antihypertensive ( P = .027) and lipid-lowering ( P = .002) medications. Although they were all in the optimal CVH score stratum (10–14 points), mean CVH scores were slightly lower in those who had CIMT in the fourth quartile (10.61 vs 10.72, P = .028), because of a small difference in the clinical CVH component (4.78 vs 4.94, P = .001). This is probably a reflex of the higher frequency of antihypertensive and lipid-lowering medication use.




Figure 2


Distribution of individuals into age-, sex-, and race-specific CIMT quartiles according to CVH score strata, for all individuals ( top ) and restricted to those without self-reported hypertension, diabetes, and/or dyslipidemia ( bottom ). We observed an increase in the proportion of individuals within the first and a decrease in the proportion of individuals within the fourth quartile with higher CVH score strata in both cases ( P for trend < .001).


Table 4

Characteristics of 1,889 individuals with optimal CVH scores, according to CIMT classification in age-, sex-, and race- specific quartiles




























































































CIMT in the first to third quartiles ( n = 1,580) CIMT in the fourth quartile ( n = 309)
Age (y) 48.7 ± 8.4 48.5 ± 8.8
Male sex 584 (37.0%) 103 (33.3%)
Race
White 1,072 (67.8%) 224 (72.5%)
Brown 356 (22.5%) 67 (21.7%)
Black 152 (9.6%) 18 (5.8%)
Smoking status
Never 1,173 (74.2%) 225 (72.8%)
Past 389 (24.6%) 77 (24.9%)
Current 18 (1.1%) 7 (2.3%)
Body mass index (kg/m 2 ) 23.7 ± 2.7 24.3 ± 2.8
Systolic blood pressure (mm Hg) 109.7 ± 10.9 110.5 ± 10.4
Diastolic blood pressure (mm Hg) 69.1 ± 7.6 69.1 ± 7.5
Fasting plasma glucose (mg/dL) 99.0 ± 9.0 99.3 ± 8.4
Total cholesterol (mg/dL) 199.4 ± 35.8 206.0 ± 37.2
LDL cholesterol (mg/dL) 119.8 ± 29.9 125.9 ± 32.4
HDL cholesterol (mg/dL) 60.8 ± 15.1 60.4 ± 14.1
Triglycerides (mg/dL) 83.0 (62.0–112.0) 88.0 (68.0–114.0)
Use of antihypertensive medication 77 (4.9%) 25 (8.1%)
Use of hypoglycemic medication 4 (0.3%) 2 (0.6%)
Use of lipid-lowering medication 71 (4.5%) 28 (9.1%)

HDL , High-density lipoprotein; LDL , low-density lipoprotein.

Data are expressed as mean ± SD, as number (percentage), or as median (interquartile range).


Table 5 shows the regression models results for the association between CIMT and a 1-point increase in CVH score. For the whole sample, all of the analyses showed that higher CVH scores were associated with lower CIMT values. A 1-point increase in CVH score was associated with a mean expected decrease of 0.011 mm in CIMT after adjustment for age, sex, and race. As a comparison, in main models, a 1-year increase in age was associated with an increase of 0.007 mm in CIMT. In addition, a 1-point increase in CVH score was associated with a decreased probability of having CIMT in the fourth quartile (odds ratio, 0.79; 95% CI, 0.77–0.81).



Table 5

Odds ratios (and 95% CIs) from multinomial models and β coefficients (and 95% CIs) from linear models for the association between CIMT and a 1-point increase in CVH score
























































































































































All sample
Men ( n = 4,269) Women ( n = 5,393) White ( n = 5,607) Brown ( n = 2,545) Black ( n = 1,510) All individuals ( n = 9,662)
Odds ratio
First quartile Reference (1.0) Reference (1.0) Reference (1.0) Reference (1.0) Reference (1.0) Reference (1.0)
Second quartile 0.94 (0.91–0.98) 0.94 (0.91–0.98) 0.94 (0.91–0.97) 0.95 (0.90–0.999) 0.95 (0.89–1.02) 0.95 (0.92–0.97)
Third quartile 0.87 (0.83–0.90) 0.90 (0.87–0.93) 0.89 (0.86–0.91) 0.89 (0.85–0.94) 0.88 (0.82–0.94) 0.89 (0.87–0.91)
Fourth quartile 0.77 (0.74–0.81) 0.79 (0.76–0.82) 0.79 (0.76–0.81) 0.78 (0.74–0.82) 0.76 (0.71–0.82) 0.79 (0.77–0.81)
β coefficient
Crude −0.019 (−0.021 to −0.017) −0.017 (−0.018 to −0.016) −0.017 (−0.018 to −0.016) −0.019 (−0.021 to −0.017) −0.021 (−0.025 to −0.018) −0.018 (−0.019 to −0.017)
Adjusted −0.013 (−0.015 to −0.011) −0.010 (−0.011 to −0.009) −0.010 (−0.011 to −0.009) −0.012 (−0.014 to −0.010) −0.013 (−0.016 to −0.010) −0.011 (−0.012 to −0.010)
No self-reported hypertension, diabetes, and/or dyslipidemia
Men ( n = 1,920) Women ( n = 2,585) White ( n = 2,720) Brown ( n = 1,193) Black ( n = 592) All individuals ( n = 4,505)
Odds ratio
First quartile Reference (1.0) Reference (1.0) Reference (1.0) Reference (1.0) Reference (1.0) Reference (1.0)
Second quartile 0.98 (0.92–1.04) 0.97 (0.92–1.02) 0.97 (0.92–1.02) 0.99 (0.92–1.06) 0.97 (0.86–1.08) 0.98 (0.94–1.01)
Third quartile 0.88 (0.83–0.93) 0.92 (0.87–0.97) 0.90 (0.86–0.95) 0.92 (0.85–0.99) 0.87 (0.78–0.98) 0.91 (0.87–0.94)
Fourth quartile 0.79 (0.74–0.84) 0.81 (0.77–0.86) 0.80 (0.75–0.84) 0.85 (0.78–0.92) 0.75 (0.66–0.85) 0.81 (0.78–0.84)
β coefficients
Crude 0.015 (−0.017 to −0.012) −0.012 (−0.014 to −0.010) −0.014 (−0.015 to −0.012) −0.013 (−0.016 to −0.010) −0.016 (−0.020 to −0.012) −0.014 (−0.015 to −0.012)
Adjusted −0.011 (−0.013 to −0.009) −0.007 (−0.009 to −0.006) −0.009 (−0.011 to −0.008) −0.007 (−0.010 to −0.005) −0.010 (−0.014 to −0.007) −0.009 (−0.010 to −0.008)

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Apr 17, 2018 | Posted by in CARDIOLOGY | Comments Off on Association between Cardiovascular Health Score and Carotid Intima-Media Thickness: Cross-Sectional Analysis of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Baseline Assessment

Full access? Get Clinical Tree

Get Clinical Tree app for offline access